I'm a Stock Trader

One frozen stock is holding fourteen positions hostage

Two names are up 35% in under three weeks. One name hasn't moved in two months.
Scoreboard Update
EXPERIMENT UPDATE — Day 60 System: +3.0% | SPY (same window): +0.0% | Alpha: +3.0% Win rate: 0% (0/18) Open positions: CRNX (day 52, +1.2%), CRNX (day 47, +0.9%), CRNX (day 46, +0.8%), CRNX (day 45, +0.6%), CRNX (day 44, +0.5%), CRNX (day 43, +0.4%), CRNX (day 40, +0.3%), CRNX (day 39, +0.2%), CRNX (day 38, +0.2%), CRNX (day 37, +0.3%), CRNX (day 36, +0.2%), CRNX (day 33, +0.2%), CRNX (day 29, +0.1%), CRNX (day 26, -0.0%), TEAM (day 17, +4.4%), TEAM (day 16, +3.4%), IOVA (day 15, +35.0%), RNG (day 12, +9.5%), TWST (day 11, +34.7%)

Today's market and our positions

IOVA is up 35%. TWST is up 34%. Before we run through the full scoreboard, those two numbers deserve a moment — because they're doing the real work on Day 60. SPY finished up 0.56% today, closing near $771.50. A decent session for the broad market — not a rip, not a reversal. The Relative Strength Engine's picks held their ground against it. That's the whole point.

What our open trades are doing

Let's go position by position, grouped where it makes sense. **IOVA (day 15, +35.6%)** — This is the one that makes you check the screen twice. We entered at $8.15; it's sitting at $11.05 now. That's not a slow grind — something fundamentally shifted in how the market is pricing this name, and the Relative Strength Engine caught it early. Still open. We're watching for any fade below recent support before we think about the exit. **TWST (day 11, +34.7%)** — Another one. Entry $135.76, now $182.83. Eleven days in and it's already shaping up as one of the system's better calls of the year. The alpha vs. SPY since entry stands at +32.8%. No complaints here. **RNG (day 12, +9.6%)** — A steadier climber, but a climber. Entry $69.55, now $76.20. Not flashy — just positive and holding. The Relative Strength Engine flagged it as the sector started to rotate, and that thesis is still intact. **TEAM (days 16 and 17, +3.4% and +4.4%)** — Two separate entries within a day of each other, both working. Entry levels were $181.65 and $179.86; both are sitting at $187.74 right now. Solid, not spectacular — and if the broader market keeps cooperating, TEAM has more room to move. **CRNX (14 open positions, days 26 through 52)** — Here's the uncomfortable part of the scoreboard. Fourteen open CRNX positions, and every single one posted +0.00% price change today. The stock is essentially frozen. Our entries ranged from $83.93 to $84.99, and the current price sits somewhere inside that exact same band, depending on which lot you're looking at. The system has been adding to this one at a steady drip for nearly two months. Some of those positions carry small positive alpha vs. SPY on down days; most carry small negative alpha on up days. There's no sugarcoating it — CRNX is a drag on attention and capital right now. We're watching for either a decisive move higher or a stop getting tagged.

Today's closed trades, post-mortem

No trades closed today. Nothing to post-mortem. The closed-trade log is clean for this session.

What could change by tomorrow's open

The concentration risk here is real, and it's worth naming directly: fourteen lots of CRNX means a single piece of news on that stock moves this portfolio more than any of the winners do right now. If CRNX gaps down hard, we're stopping out of a lot of positions at once. That's the math. On the other side of the ledger, IOVA and TWST have both moved far enough that a mean-reversion pullback in either would sting. The system doesn't predict reversals — but after a 34–35% run in under three weeks, we'd be naive not to have tight eyes on both.

What we're watching tomorrow

Tomorrow morning the engines scan fresh. Whether CRNX finally breaks out of its freeze or stays glued to that $83–$84 band is probably the most interesting question heading into the open — fourteen positions hanging on the same answer is a strange kind of suspense.

See how the system backtests →

How our rebuilt system performs against the S&P 500 in testing — year by year, with the honest caveats.


Keep exploring